Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized , Double Blind, Placebo Controlled, 3-Arm Parallel Design Study to Evaluate the Effects of BPN14770 in Patients With Early Stage Alzheimer's Disease

NCT03817684 is registered in ClinicalTrials.gov with Tetra Discovery Partners as lead sponsor.

NCT NCT03817684
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03817684 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized , Double Blind, Placebo Controlled, 3-Arm Parallel Design Study to Evaluate the Effects of BPN14770 in Patients With Early Stage Alzheimer's Disease
Lead sponsor
Tetra Discovery Partners
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2019
Completion date
February 4, 2020
Enrollment
255 (actual)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease